Skip to main content
SpringerLink
Log in

Two types of ectopic Cushing syndrome or a continuum? Review

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Background

Two types of ectopic Cushing syndrome (ECS) are described: ECS associated with aggressive neoplasms, and ECS with indolent and occult tumors, however, there is a lack of studies that thoroughly review their characteristics.

Methods

A systematic review was carried out on PUBMED of all the papers about the ECS, in order to better define the types of this subcategory of Cushing’s syndrome, highlighting the differential aspects between these subgroups.

Results

It was found that in 50% of cases the prototypic “aggressive” ECS is caused by small cell lung carcinomas (SCLC). In these cases, the clinical presentation may be atypical, predominating the signs and symptoms derived from the protein catabolism. Cortisol and ACTH levels are extremely high, the clinical presentation is abrupt (< 3–6 months) and the tumor is usually advanced, being impossible a curative treatment. On the other hand, “indolent” ECS is mainly represented by carcinoid tumors (CT). In these cases the clinical presentation overlaps enormously with that of Cushing’s disease (CD). Cortisol and ACTH levels are slightly elevated, the clinical presentation is progressive (> 6 months) and the prognosis is usually good, and a curative treatment is possible in about 75% of the cases.

Conclusion

Although there is no absolute differentiation between the two extremes of ECS, a classification could be established in two groups, guided by its clinical and biochemical characteristics, and mainly by the type and stage of the ACTH-secreting tumor. However, a small percentage of tumors do not fit in this simple grouping, and may present both phenotypes or an intermediate one.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Newell-Price J (2009). Diagnosis/differential diagnosis of Cushing’s syndrome: a review of best practice. Best Pract Res Clin Endocrinol Metab 23(1):S5–S14. https://doi.org/10.1016/S1521-690X(09)70003-X

    Article  PubMed  Google Scholar 

  2. Sharma ST, Nieman LK, Feelders RA (2015) Cushing’s syndrome: Epidemiology and developments in disease management. Clin Epidemiol 7:281–293

    PubMed  PubMed Central  Google Scholar 

  3. Newell-Price J, Bertagna X, Grossman A, Nieman L (2006) Cushing’s syndrome. Lancet 367(9522):1605–1617

    Article  PubMed  CAS  Google Scholar 

  4. Newell-Price J, Trainer P, Besser M, Grossman A (1998) The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocrin Rev 19(5):647–672

    CAS  Google Scholar 

  5. Isidori AM, Kaltsas GA, Pozza C, Frajese V, Newell-Price J, Reznek RHA et al (2006) The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab 91(2):371–377

    Article  PubMed  CAS  Google Scholar 

  6. Isidori AM, Lenzi A (2007) Overt and occult ectopic ACTH Syndrome. Arq Bras Endocrinol Metab 51(8):1217–1225

    Article  Google Scholar 

  7. Liddle GW, Givens R, Nicholson E, Island P (1965) The ectopic ACTH syndrome. Cancer Res 25(7):1057–1061

    PubMed  CAS  Google Scholar 

  8. Aniszewski JP, Young WF Jr, Thompson GB, Grant CS, van Heerden JA (2001) Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. World J Surg 25(7):934–940

    Article  PubMed  CAS  Google Scholar 

  9. Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley R, Nieman LK (2005) Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J Clin Endocrinol Metab 90(8):4955–4962

    Article  PubMed  CAS  Google Scholar 

  10. Ejaz S, Vassilopoulou-Sellin R, Busaidy NL, Hu MI, Waguespack SG, Jimenez C et al (2011) Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience. Cancer 117(19):4381–4389

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Ferone D, Albertelli M (2014) Ectopic Cushing and other paraneoplastic syndromes in thoracic neuroendocrine tumors. Thorac Surg Clin 24(3):277–283

    Article  PubMed  Google Scholar 

  12. Duran C, Eren Karanis M, Bakdik S, Aslan U, Calik M, Calik S (2016) Ectopic Cushing syndrome due to ACTH secreting atypic thymic carcinoid tumor. Chest 150(4):50A

    Article  Google Scholar 

  13. Phan AT, Yao JC (2008) Neuroendocrine tumors: novel approaches in the age of targeted therapy. Oncology 22(14):1617–1629

    PubMed  Google Scholar 

  14. Litvak A, Pietanza MC (2016) Bronchial and thymic carcinoid tumors. Hematol Oncol Clin N Am 30(1):83–102

    Article  Google Scholar 

  15. Wang WQ, Ye L, Bi YF, Zhao HY, Sun SY, Tang ZY et al (2006) Six cases of ectopic ACTH syndrome caused by thymic carcinoid. J Endocrinol Invest 29(4):293–297

    Article  PubMed  CAS  Google Scholar 

  16. De Perrot M, Spiliopoulos A, Fischer S, Totsch M, Keshavjee S (2002) Neuroendocrine carcinoma (carcinoid) of the thymus associated with Cushing’ s syndrome. Ann Thorac Surg 73(2):675–681

    Article  PubMed  Google Scholar 

  17. Ballav C, Naziat A, Mihai R, Karavitaki N, Ansorge O, Grossman AB (2012) Mini-review: pheochromocytomas causing the ectopic ACTH syndrome. Endocrine 42(1):69–73

    Article  PubMed  CAS  Google Scholar 

  18. Stewart PM, Gibson S, Crosby SR, Penn R, Holder R, Ferry DP et al (1994) ACTH precursors characterize the ectopic ACTH syndrome. Clin Endocrinol 40(2):199–204

    Article  CAS  Google Scholar 

  19. Raffin-Sanson ML, Massias JF, Dumont C, Raux-Demay MC, Proeschel MF, Luton JP et al (1996) High plasma proopiomelanocortin in aggressive adrenocorticotropin-secreting tumors. J Clin Endocrinol Metab 81(12):4272–4277

    PubMed  CAS  Google Scholar 

  20. Terzolo M, Reimondo G, Alì A, Bovio S, Daffara F, Paccotti PM et al (2011) Ectopic ACTH syndrome: molecular bases and clinical heterogeneity. Ann Oncol 12(2):S83–S7

    Google Scholar 

  21. De Keyzer Y, Lenne F, Auzan C, Jégou S, René P, Vaudry HY et al (1996) The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome. J Clin Invest 97(5):1311–1318

    Article  PubMed  PubMed Central  Google Scholar 

  22. De Keyzer Y, Auzan C, Lenne F, Beldjord C, Thibonnier M, Bertagna XY et al (1994) Cloning and characterization of the human V3 pituitary vasopressin receptor. FEBS Lett 356(2–3):215–220

    Article  PubMed  Google Scholar 

  23. Suda T, Tozawa F, Dobashi I, Horiba N, Ohmori N, Yamakado M et al (1993) Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro. J Clin Invest 92(6):2790–2795

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Wajchenberg BL, Mendonca BB, Liberman B, Pereira MA, Carneiro PC, Wakamatsu A et al (1994) Ectopic Adrenocorticotropic Hormone Syndrome. Endocr Rev 15(6):752 – 87

    PubMed  CAS  Google Scholar 

  25. Sathyakumar S, Paul TV, Asha HS, Gnanamuthu BR, Paul MJ, Abraham DT et al (2017) Ectopic Cushing syndrome: a 10-year experience from a tertiary care center in southern India. Endocr Pract 23(8):907–914

    Article  PubMed  Google Scholar 

  26. Viebahn R, Hiddemann W, Klink F, Bassewitz DB (1985) Thymus carcinoid. Pathol Res Pract 180(4):445–448

    Article  PubMed  CAS  Google Scholar 

  27. Wick MR, Scott RE, Li CY, Carney JA (1980) Carcinoid tumor of the thymus: a clinicopathologic report of seven cases with a review of the literature. Mayo Clin Proc 55(4):246–254

    PubMed  CAS  Google Scholar 

  28. Debelenko LV, Brambilla E, Agarwal SK, Swalwell JI, Kester MB, Lubensky IA et al (1997) Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 6(13):2285–2290

    Article  PubMed  CAS  Google Scholar 

  29. Gibril F, Chen YJ, Schrump DS, Vortmeyer A, Zhuang Z, Lubensky IA et al (2003) Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 88(3):1066–1081

    Article  PubMed  CAS  Google Scholar 

  30. Wick MR, Rosai J (1988) Neuroendocrine Neoplasms of the Thymus. Pathol Res Pract 183(2):188–199

    Article  PubMed  CAS  Google Scholar 

  31. Quinkler M, Stewart PM (2003) Hypertension and the cortisol-cortisone shuttle. J Clin Endocrinol Metab 88(6):2384–2392

    Article  PubMed  CAS  Google Scholar 

  32. Crapo L (1979) Cushing’s syndrome: a review of diagnostic tests. Metabolism 28(9):955–977

    Article  PubMed  CAS  Google Scholar 

  33. Karageorgiadis AS, Papadakis GZ, Biro J, Keil MF, Lyssikatos C, Quezado MM et al (2015) Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone co-secreting tumors in children and adolescents causing Cushing syndrome: a diagnostic dilemma and how to solve it. J Clin Endocrinol Metab 100(1):141–148

    Article  PubMed  CAS  Google Scholar 

  34. Flack MR, Oldfield EH, Cutler GB Jr, Zweig MH, Malley JD, Chrousos GP et al (1992) Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome. Ann Intern Med 116(3):211–217

    Article  PubMed  CAS  Google Scholar 

  35. Malchoff CD, Orth DN, Abboud C, Carney JA, Pairolero PC, Carey RM (1988) Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor. Am J Med 84(4):760–764

    Article  PubMed  CAS  Google Scholar 

  36. Lamas Oliveira C, Martínez JA, Corrales PP, Rodríguez SA, López H (2007) Metodología diagnóstica en la identificación del Cushing ectópico. Endocrin y Nutr 54(8):432 – 37

    Article  Google Scholar 

  37. Ritzel K, Beuschlein F, Berr C, Osswald A, Reisch N, Bidlingmaier M et al (2015) ACTH after 15 min distinguishes between Cushing’s disease and ectopic Cushing’s syndrome: a proposal for a short and simple CRH test. Eur J Endocrinol 173(2):197–204. https://doi.org/10.1530/EJE-14-0912

    Article  PubMed  CAS  Google Scholar 

  38. Barbot M, Trementino L, Zilio M, Ceccato F, Albiger N, Daniele A et al (2016) Second-line tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome. Pituitary 19(5):488 – 95. https://doi.org/10.1007/s11102-016-0729-y

    Article  PubMed  CAS  Google Scholar 

  39. Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL et al (2003) Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 88(11):5299–5306

    Article  PubMed  CAS  Google Scholar 

  40. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP et al (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88(12):5593–5602

    Article  PubMed  CAS  Google Scholar 

  41. Bansal V, Asmar N, Selman WR, Arafah BM (2015) Pitfalls in the diagnosis and management of Cushing’s syndrome. Neurosurg Focus 38(2):1–11

    Article  Google Scholar 

  42. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA et al (1991) Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing’s syndrome. N Engl J Med 325(13):897–905

    Article  PubMed  CAS  Google Scholar 

  43. Zampetti B, Grossrubatscher E, Dalino Ciaramella P, Boccardi E, Loli P (2016) Bilateral inferior petrosal sinus sampling. Endocr Connect 5(4):R12-25

    Article  PubMed  CAS  Google Scholar 

  44. Gahtany M, Bilbao J, Kovacs K, Horvath E, Smyth HS (2003) Juxtaposition of an ectopic corticotroph adenoma of the sphenoid sinus with orthotopic intrasellar corticotroph hyperplasia in a patient with Cushing disease: Case report. J Neurosurg 98(4):891–896

    Article  Google Scholar 

  45. Doppman JL, Pass HI, Nieman LK, Findling JW, Dwyer AJ, Feuerstein IM et al (1991) Detection of ACTH-producing bronchial carcinoid tumors: MR imaging vs CT. AJR Am J Roentgenol 156(1):39–43

    Article  PubMed  CAS  Google Scholar 

  46. Boscaro M, Arnaldi G (2009) Approach to the patient with possible Cushing’s syndrome. J Clin Endocrinol Metab 94(9):3121–3131

    Article  PubMed  CAS  Google Scholar 

  47. Deldycke A, Haenebalcke C, Taes Y (2017) Paraneoplastic Cushing syndrome, case-series and review of the literature. Acta Clin Belg 12:1–7

    Google Scholar 

  48. Shrager JB, Wright CD, Wain JC, Torchiana DF, Grillo HC, Mathisen DJ (1997) Bronchopulmonary carcinoid tumors associated with Cushing’s syndrome: A more aggressive variant of typical carcinoid. J Thorac Cardiovasc Surg 114(3):367 – 75

    Article  PubMed  CAS  Google Scholar 

  49. Estopiñán V, Varela C, Riobo P, Dominguez JR, Sancho J (1987) Ectopic Cushing’s syndrome with periodic hormonogenesis–a case suggesting a pathogenetic mechanism. Postgrad Med J 63(744):887–889

    Article  PubMed  PubMed Central  Google Scholar 

  50. Özkan ZG, Kuyumcu S, Balköse D, Ozkan B, Aksakal N, Yılmaz EZ et al (2013) The value of somatostatin receptor imaging with In-111 Octreotide and/or Ga-68 DOTATATE in localizing Ectopic ACTH producing tumors. Mol Imaging Radionucl Ther 22(2):49–55

    Article  PubMed  PubMed Central  Google Scholar 

  51. Kwekkeboom DJ, Krenning EP, Bakker WH, Oei HY, Kooij PP, Lamberts SW (1993) Somatostatin analogue scintigraphy in carcinoid tumours. Eur J Nucl Med 20(4):283–292

    Article  PubMed  CAS  Google Scholar 

  52. Reincke M, Allolio B, Arlt W, Körber C (1999) Comment on primary localization of an ectopic ACTH-producing bronchial carcinoid tumor by Indium111 pentetreotide scintigraphy. J Clin Endocrinol Metab 84(9):3399–3400

    Article  PubMed  CAS  Google Scholar 

  53. De Bruin C, Hofland LJ, Nieman LK, van Koetsveld PM, Waaijers AM, Sprij-Mooij DM et al (2012) Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing’s syndrome due to ectopic adrenocorticotropin secretion. J Clin Endocrino Metab 97(2):455–462

    Article  CAS  Google Scholar 

  54. Petersenn S, Rasch AC, Presch S, Beil FU, Schulte HM (1999) Genomic structure and transcriptional regulation of the human somatostatin receptor type 2. Mol Cell Endocrinol 157(1–2):75–85

    Article  PubMed  CAS  Google Scholar 

  55. Pacak K, Ilias I, Chen CC, Carrasquillo JA, Whatley M, Nieman LK (2004) The role of [18F]fluorodeoxyglucose positron emission tomography and [111In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing’s syndrome. J Clin Endocrinol Metab 89(5):2214–2221

    Article  PubMed  CAS  Google Scholar 

  56. Treglia G, Castaldi P, Rindi G, Giordano A, Rufini V (2012) Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis. Endocrine 42(1):80–87

    Article  PubMed  CAS  Google Scholar 

  57. Grossman AB, Kelly P, Rockall A, Bhattacharya S, McNicol A, Barwick T (2006) Cushing’s syndrome caused by an occult source: difficulties in diagnosis and management. Nat Clin Pract Endocrinol Metab 2(11):642–647

    Article  PubMed  Google Scholar 

  58. Meinardi JR, Wolffenbuttel BH, Dullaart RP (2007) Cyclic Cushing’s syndrome: a clinical challenge. Eur J Endocrinol 157(3):245–254

    Article  PubMed  CAS  Google Scholar 

  59. Brown RD, Van Loon GR, Orth DN, Liddle GW (1973) Cushing’s disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone. J Clin Endocrinol Metab 36(3):445–451

    Article  PubMed  CAS  Google Scholar 

  60. Orth DN (1995) Cushing’s syndrome. N Engl J Med 332(12):791–803

    Article  PubMed  CAS  Google Scholar 

  61. Bailey RE (1971) Periodic hormonogenesis-a new phenomenon. periodicity in function of a hormone-producing tumor in man. J Clin Endocrinol Metab 32(3):317–327

    Article  PubMed  CAS  Google Scholar 

  62. Sharma ST, Nieman LK (2012) Prolonged remission after long-term treatment with steroidogenesis inhibitors in Cushing’s syndrome caused by ectopic ACTH secretion. Eur J Endocrinol 166(3):531–536

    Article  PubMed  CAS  Google Scholar 

  63. Loh KC, Gupta R, Shlossberg AH (1996) Spontaneous remission of ectopic Cushing’s syndrome due to pheochromocytoma: a case report. Eur J Endocrinol 135(4):440–443

    Article  PubMed  CAS  Google Scholar 

  64. Liebowitz G, White A, Hadani M, Gross DJ (1997) Fluctuating hyper-hypocortisolaemia: a variant of Cushing’s syndrome. Clin Endocrinol 46(6):759–763

    Article  CAS  Google Scholar 

  65. Peri A, Bemporad D, Parenti G, Luciani P, Serio M, Mannelli M (2001) Cushing’s syndrome due to intermittent ectopic ACTH production showing a temporary remission during a pulmonary infection. Eur J Endocrinol 145(5):605–611

    Article  PubMed  CAS  Google Scholar 

  66. Atkinson AB, McCance DR, Kennedy L, Sheridan B (1992) Cyclical Cushing’s syndrome first diagnosed after pituitary surgery: a trap for the unwary. Clin Endocrinol 36(3):297–299

    Article  CAS  Google Scholar 

  67. Mercado-Asis LB, Murayama M, Yamakita N, Morita H, Mune T, Yasuda KL et al (1991) Cortisol-suppressible dexamethasone-nonsuppressible cyclic Cushing’s disease with evidence of clinical and biochemical remission with bromocriptine. Endocrinol Jpn 38(3):315–324

    Article  PubMed  CAS  Google Scholar 

  68. Mullan KR, Atkinson AB, Sheridan B (2007) Cyclical Cushing’s syndrome: an update. Curr Opin Endocrinol Diabetes Obes 14(4):317–322

    Article  PubMed  Google Scholar 

  69. Kakade HR, Kasaliwal R, Jagtap VS, Bukan A, Budyal SR, Khare SH et al (2013) Ectopic ACTH-secreting syndrome: a single-center experience. Endocr Pract 19(6):1007–1014

    Article  PubMed  Google Scholar 

  70. Li WY, Liu XD, Li WN, Dong SY, Qu XH, Gong SL et al (2016) Paraneoplastic Cushing’s syndrome associated with bronchopulmonary carcinoid tumor in youth: a case report and review of the literature. Oncol Lett 12(1):69–72

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  71. Hilal T (2017) Current understanding and approach to well differentiated lung neuroendocrine tumors: an update on classification and management. Ther Adv Med Oncol 9(3):189–199

    Article  PubMed  Google Scholar 

  72. Maragliano R, Vanoli A, Albarello L, Milione M, Basturk O, Klimstra DS et al (2015) ACTH-secreting pancreatic neoplasms associated with Cushing syndrome: clinicopathologic study of 11 cases and review of the literature. Am J Surg Pathol 39(3):374–382

    Article  PubMed  Google Scholar 

  73. Farrell WE, Stewart MF, Clark AJ, Crosby SR, Davis JR, White A (1993) Glucocorticoid inhibition of ACTH peptides: small cell lung cancer cell lines are more resistant than pituitary corticotroph adenoma cells. J Mol Endocrinol 10(1):25–32

    Article  PubMed  CAS  Google Scholar 

  74. Page-Wilson G, Freda PU, Jacobs TP, Khandji AG, Bruce JN, Foo ST et al (2014) Clinical utility of plasma POMC and AgRP measurements in the differential diagnosis of ACTH-dependent Cushing’s syndrome. J Clin Endocrinol Metab 99(10):E1838–E45

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  75. Kameya T, Shimosato Y, Adachi I, Abe K, Kasai N, Kimura K et al (1997) Immunohistochemical and ultrastructural analysis of medullary carcinoma of the thyroid in relation to hormone production. Am J Pathol 89(3):555–574

    Google Scholar 

  76. Patel FB, Khagi S, Daly KP, Lechan RM, Ummaritchot V, Saif MW (2013) Pancreatic neuroendocrine tumor with ectopic adrenocorticotropin production: a case report and review of literature. Anticancer Res 33(9):4001–4005

    PubMed  Google Scholar 

  77. Barbosa SL, Rodien P, Leboulleux S, Niccoli-Sire P, Kraimps JL, Caron PB et al (2005) Ectopic adrenocorticotropic hormone-syndrome in medullary carcinoma of the thyroid: a retrospective analysis and review of the literature. Thyroid 15(6):618–623

    Article  PubMed  Google Scholar 

  78. Delisle L, Boyer MJ, Warr D, Killinger D, Payne D, Yeoh JL et al (1993) Ectopic corticotropin syndrome and small-cell carcinoma of the lung. Clinical features, outcome, and complications. Arch Intern Med 153(6):746–752

    Article  PubMed  CAS  Google Scholar 

  79. Zaydfudim V, Stover DG, Caro SW, Phay JE (2008) Presentation of a medullary endocrine neoplasia 2A kindred with Cushing’s syndrome. Am Surg 74(7):659–661

    PubMed  Google Scholar 

  80. Ghazi AA, Abbasi Dezfooli A, Amirbaigloo A, Daneshvar Kakhki A, Mohammadi F, Tirgari F et al (2015) Ectopic Cushing’s syndrome secondary to lung and mediastinal tumours—report from a tertiary care centre in Iran. Endokrynol Pol 66(1):2–9

    Article  PubMed  CAS  Google Scholar 

  81. Isidori AM, Sbardella E, Zatelli MC, Boschetti M, Vitale G, Colao A et al (2015) Conventional and nuclear medicine imaging in ectopic Cushing’s syndrome: a systematic review. J Clin Endocrinol Metab 100(9):3231–3244

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  82. Kato Y, Ferguson TB, Bennett DE, Burford TH (1969) Oat cell carcinoma of the lung: a review of 138 cases. Cancer 23(3):517–524

    Article  PubMed  CAS  Google Scholar 

  83. Shepherd FA, Laskey J, Evans WK, Goss PE, Johansen E, Khamsi F (1992) Cushing’s syndrome associated with ectopic corticotropin production and small-cell lung cancer. J Clin Oncol 10(1):21–27

    Article  PubMed  CAS  Google Scholar 

  84. Howlett TA, Rees LH, Besser GM (1985) Cushing’s syndrome. Clin Endocrinol Metab 14(4):911–945

    Article  PubMed  CAS  Google Scholar 

  85. Kanaji N, Watanabe N, Kita N, Bandoh S, Tadokoro A, Ishii T et al (2014) Paraneoplastic syndromes associated with lung cancer. World J Clin Oncol 5(3):197–223

    Article  PubMed  PubMed Central  Google Scholar 

  86. Small M, Lowe GD, Forbes CD, Thomson JA (1983) Thromboembolic complications in Cushing’s syndrome. Clin Endocrinol 19(4):503–511

    Article  CAS  Google Scholar 

  87. Jeong C, Lee J, Ryu S, Lee HY, Shin AY, Kim JS et al (2015) A case of ectopic adrenocorticotropic hormone syndrome in small cell lung cancer. Tuberc Respir Dis 78(4):436–439

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department Endocrinology, Hospital Universitario de la Princesa, Madrid, Spain

    Marta Araujo Castro & Mónica Marazuela Azpiroz

  2. Department Endocrinology, Hospital Universitario Rey Juan Carlos, Madrid, Spain

    Marta Araujo Castro

Authors
  1. Marta Araujo Castro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mónica Marazuela Azpiroz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marta Araujo Castro.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Araujo Castro, M., Marazuela Azpiroz, M. Two types of ectopic Cushing syndrome or a continuum? Review. Pituitary 21, 535–544 (2018). https://doi.org/10.1007/s11102-018-0894-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-018-0894-2

Keywords

Search

Navigation